Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
Status:
Recruiting
Trial end date:
2024-03-24
Target enrollment:
Participant gender:
Summary
This phase III trial studies how well bupropion works in reducing cancer related fatigue in
stage I-III breast cancer survivors. Bupropion is a drug that is used to treat depression, as
well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving
bupropion may improve cancer related fatigue in breast cancer survivors.
Phase:
Phase 3
Details
Lead Sponsor:
Gary Morrow University of Rochester NCORP Research Base